title: Hormone replacement therapy and cancer.
abstract: The benefits of hormone replacement therapy in alleviating climacteric symptoms, preventing osteoporosis and reducing the incidence of cardiovascular disease and stroke are now generally agreed. Nonetheless, perhaps only 5% of postmenopausal women currently receive adequate treatment often because of patient or clinician fears that such treatment may be associated with harmful side effects.
authors.affiliation: Dulwich Hospital, London.
authors.forename: R J
authors.initials: RJ
authors.lastname: Baber
authors.forename: J W
authors.initials: JW
authors.lastname: Studd
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D045166:Estradiol Congeners / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005833:Genital Neoplasms, Female / Q000139:chemically induced; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced*; D010024:Osteoporosis / Q000517:prevention & control; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D045166:Estradiol Congeners; D045167:Progesterone Congeners